J B CHEMICALS AND PHARMA

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 23, 2017, titled "Press Release".

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 10, 2017, titled "StockExchange-NSE letters/MM:SA:660 February 10, 2017National Stock Exchange of India LimitedExchange PlazaBandra Kurla ComplexBandra (E), Mumbai 400 051Stock Symbol: JBCHEPHARMDear Sir,Sub : Press Release Enclosed is a press release we propose to issue on unaudited financial results for the quarter ended on December 31, 2016.Kindly take the same on record.Thanking you, Yours faithfully, for J.B. Chemicals & Pharmaceuticals LimitedM. C

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 18, 2016, titled "Press Release".

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 26, 2016 titled "Unaudited Financial Results for Q1 - 2016-17".

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 20, 2016 regarding Audited Financial Results for Q4 and the year 2015-16.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 03, 2016, with respect to the financial Results for the quarter ended December 31, 2015.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 04, 2015 titled " Unaudited Financial Results Q 2- 2015-16 ".

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding press release dated August 5, 2015 on unaudited financial results for the quarter ended on June 30, 2015.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Press Release issued on audited financial results for the year ended on March 31, 2015.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 4, 2015 titled "Unaudited Financial Results for Q3 - 2014-15".

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 10, 2014, titled "Unaudited Financial Results Q2 -2014-15 ".

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 5, 2014 titled "J.B. Chemicals reports robust bottom-line growth".

JB Chemicals & Pharmaceuticals Limited has submitted to the Exchange a copy of press release dated May 26, 2014 titled "Audited Financial Results for the year 2013-14."

JB Chemicals & Pharmaceuticals Limited has submitted a copy of press release for the unaudited financial results for the quarter/ nine months ended on December 31, 2013.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 30, 2013, titled "Sales up by 17%, Profit from operations up by 61%; Unaudited Financial Results for Q 2- 2013-14".

JB Chemicals & Pharmaceuticals Limited has informed the Exchange, vide letter dated October 22, 2013 regarding a press release by the Company on ANDA approval received from US FDA for Tinidazole 250 mg and 500 mg tablets.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 26, 2013 in respect of the unaudited financial results for the quarter ended on June 30, 2013.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 24, 2013, titled "Revenue Growth:19%-PBT(before exceptional item) Growth:122%, Audited Financial Results for the year 2012-13"

JB Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 05, 2013, titled "Unaudited Financial Results for Q3 - 2012-13".

Jb Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 01, 2012, titled "Unaudited Financial Results for Q2-2012-13."

Jb Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 06, 2012, titled "Unaudited Financial Results for Q1-2012-13."

Jb Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 23, 2012, titled "Audited Financial Results for the year 2011-12."

Jb Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 25, 2012, titled "J.B.Chemicals: Financial Results for Q3 2011-12."

Jb Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 19, 2011, titled "J.B.Chemicals: Financial Results for Q2 2011-12."

Jb Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 26, 2011 that the company plans to issue in connection with mutual calling off of the proposed prescription products deal between the company and Dr. Reddy's Laboratories Limited ("DRL") that involved sale of the company's Russia-CIS prescription products business to DRL.

Jb Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 19, 2011, titled "J.B.Chemicals declares handsome onetime special dividend".

Jb Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 29, 2011, issued by the Company on the unaudited financial results for the quarter ended on June 30, 2011.

Jb Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 22, 2011, titled "Jb Chemicals & Pharmaceuticals Limited to sell its Russia-CIS Rx Business to Dr.Reddy's Laboratories Limited, Hyderabad"

Jb Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 14, 2011, titled "J.B. Chemicals announces completion of its transaction of Sale of Russia-CIS OTC Business to Cilag GmbH International"

Jb Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated June 30, 2011, titled "J.B.Chemicals launches a New Domestic Division".

Jb Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 23, 2011, titled "J.B.Chemicals declares good set of numbers for 2010-11".

Jb Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 13, 2011, titled "J.B.Chemicals reports robust profits in Q3".

Jb Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a Press Release dated December 02, 2010, titled " J.B.Chemicals receives US FDA approval for Diclofenac Sodium Tablets".

Jb Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 26, 2010, titled "J.B. Chemicals continues growth march in Q2".

Jb Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 29, 2010, titled "J.B.Chemicals posts healthy performance in Q1".

Jb Chemicals & Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 05, 2010, titled "J. B. Chemicals declares robust profits for 2009-10".

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding a press release, dated January 28, 2010, with respect to unaudited financial results for the quarter ended on December 31, 2009. A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/JBCHEM_PR_28012010.zip target=NEW> For more details click here.</a>

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding a press release, dated October 26, 2009, on unaudited financial results for the quarter ended on September 30, 2009. A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/JbChem_PR_26102009.zip target=NEW> For more details click here.</a>

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding a press release dated August 28, 2009 regarding "Jb Chemicals & Pharmaceuticals Ltd. (JBCPL) announces the receipt of US FDA Approval to the it's Abbreviated New Drug Application (ANDA) for Cetirizine Hydrocholoride (anti-allergic) 5 mg. and 10 mg. Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/JBCHEMICAL_PR_28082009.zip target=NEW> For mor

Jb Chemicals & Pharmaceuticals Ltd. has submitted to the Exchange a copy of the press release on Unaudited Financial Results for the quarter ended on June 30, 2009. A copy of the press release be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/JBCHEMICALS_PR_22072009.zip target=NEW> For more details click here.</a>

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding press release with respect to audited financial results for the year ended on March 31, 2009. A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/JBC_pr_13052009.zip target=NEW> For more details click here.</a>

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding press release on unaudited financial results for the quarter / nine months ended on December 31, 2008. A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/JbChem_PR_23012009.zip target=NEW> For more details click here.</a>

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding a press release dated October 20, 2008, with respect to Unaudited Financial Results of the Company for the second quarter/half-year ended September 30, 2008. A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/jbchempharm_PR_22102008.zip target=NEW> For more details click here.</a>

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding a press release dated July 25, 2008, with respect to Unaudited Financial Results of the Company for the quarter ended June 30, 2008. A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/JBChemical_PR_28072008.zip target=NEW> For more details click here.</a>

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange vide its letter dated May 14, 2008 regarding a press release dated May 08, 2008, titled "J.B. Chemicals & Pharmaceuticals Limited Announces Audited Financial Results for FY 2007-08; Recommends 25% Dividend". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/JBChemicals_RP_15052008.zip target=NEW> For more details click here.</a>

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding a press release dated April 08, 2008, titled "J.B. Chemicals & Pharmaceuticals Limited Board approves Share Buyback at a maximum price of Rs.70/- per share". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/JBCHEM_PR_10042008.zip target=NEW> For more details click here.</a>

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding a press release dated January 29, 2008, titled "J.B. Chemicals & Pharmaceuticals Limited announces Unaudited Financial Results for the third quarter ended 31st December, 2007". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/JBChem_PR_30012008.zip target=NEW> For more details click here.</a>

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding a press release dated January 09, 2008, titled "JBCPL receives EU GMP Approval". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/JBChemicals_PR_09012008.zip target=NEW> For more details click here.</a>

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding a Press Release dated October 30, 2007 titled as "J. B. Chemicals & Pharmaceuticals Limited Announces Unaudited Financial Results for the second quarter ended September 30, 2007". A copy of the Press Release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/JBChemicals_PR_30102007.zip target=NEW> For more details click here.</a>

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange regarding a Press Release dated July 28, 2007 titled as "J. B. Chemicals & Pharmaceuticals Limited Announces Unaudited Financial Results for the first quarter ended June 30, 2007". A copy of the Press Release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/JBChemicals_PR1_01082007.zip target=NEW> For more details click here.</a>